Skip to main content
  • Double, Triple Antithrombotics No Better in Afib After TAVR More bleeding, no fewer CV events in observational study

    Antiplatelet agents added to anticoagulation with warfarin and other vitamin K antagonists was associated with more major bleeding but not better outcomes following transcatheter aortic valve replacement (TAVR) in patients with atrial fibrillation (Afib), a multicenter observational study showed.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details